Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) is a listed company. Its insiders report their share dealings to SEDI. The past year has been quiet: not a single insider filing for Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.). The previous disclosure was published on 1 October 2023.
Our records for Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) go back to 2019, with 9 purchases and 6 sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
· cache
25 of 98 declarations
Liminal BioSciences Inc. is a biopharmaceutical company focused on developing innovative therapies for rare diseases and metabolic disorders. Formerly known as Prometic Life Sciences Inc., it is listed on the XTSE.